报告地点： A5楼 201会议室
Dr. Hui Tian is the CEO of Angstrom Biotechnologies in Silicon Valley, as well as a R&D Center Director at Shenzhen Tsinghua Research Institute. Prior to that he was the Vice President of Roche Sequencing Unit, and the Vice President of Genia Technologies. Dr. Tian has extensive DNA sequencing, nanotech material, image sensors and semiconductor engineering experience. He has held senior technology and engineering leadership positions at multiple high-tech companies in Silicon Valley, taking many products into biotech and nanotech markets. Dr. Tianearned his PhD and MSdegrees from Stanford University, and MS and BS degrees from Tsinghua University. He holds over forty US patents.